Back to Results
First PageMeta Content
Nose / Glucocorticoids / Organochlorides / Schering-Plough / Mometasone furoate / Nasal spray / Nasal congestion / Allergic rhinitis / Fluticasone propionate / Medicine / Pulmonology / Allergology


DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857
Add to Reading List

Open Document

File Size: 47,56 KB

Share Result on Facebook

City

Beltsville / MSPAS / MACMIS / Kenilworth / /

Company

Valerie K. Cotler Schering Corporation / Global Labeling / Promotion Global Regulatory Affairs Schering Corporation / Roper / Schering Corporation / /

Event

FDA Phase / /

/

IndustryTerm

treatment of the nasal symptoms / online survey / /

MedicalCondition

moderate-to-severe perennial allergic rhinitis / nasal polyps / perennial allergic rhinitis / nasal congestion / itching / Nasal allergy / allergic rhinitis / seasonal allergic rhinitis / seasonal and perennial allergic rhinitis / seasonal allergic and perennial allergic rhinitis / /

Organization

Food and Drug Administration / U.S. Food and Drug Administration / Division of Drug Marketing / Advertising / and Communications / DEPARTMENT OF HEALTH / /

Person

Nasonex / Michelle Safarik / /

Position

AM/PM / Officer / /

Product

fluticasone propionate / Nasonex / Flonase / mometasone furoate / I94-079 / Nasonex® / /

ProvinceOrState

New Jersey / Maryland / /

SocialTag